These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 12477763)

  • 1. CARD4/NOD1 is not involved in inflammatory bowel disease.
    Zouali H; Lesage S; Merlin F; Cézard JP; Colombel JF; Belaiche J; Almer S; Tysk C; O'Morain C; Gassull M; Christensen S; Finkel Y; Modigliani R; Gower-Rousseau C; Macry J; Chamaillard M; Thomas G; Hugot JP; ;
    Gut; 2003 Jan; 52(1):71-4. PubMed ID: 12477763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOD2/CARD15, NOD1/CARD4, and ICAM-1 gene polymorphisms in Turkish patients with inflammatory bowel disease.
    Ozen SC; Dagli U; Kiliç MY; Törüner M; Celik Y; Ozkan M; Soykan I; Cetinkaya H; Ulker A; Ozden A; Bozdayi AM
    J Gastroenterol; 2006 Apr; 41(4):304-10. PubMed ID: 16741608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of NOD1/CARD4 variation in inflammatory bowel disease using a haplotype-tagging strategy.
    Van Limbergen J; Nimmo ER; Russell RK; Drummond HE; Smith L; Anderson NH; Davies G; Arnott ID; Wilson DC; Satsangi J
    Hum Mol Genet; 2007 Sep; 16(18):2175-86. PubMed ID: 17613538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of the NOD1/CARD4 insertion/deletion polymorphism +32656 to inflammatory bowel disease in Northern Europe.
    Van Limbergen J; Russell RK; Nimmo ER; Törkvist L; Lees CW; Drummond HE; Smith L; Anderson NH; Gillett PM; McGrogan P; Hassan K; Weaver LT; Bisset WM; Mahdi G; Arnott ID; Sjöqvist U; Lördal M; Farrington SM; Dunlop MG; Wilson DC; Satsangi J
    Inflamm Bowel Dis; 2007 Jul; 13(7):882-9. PubMed ID: 17285593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease.
    McGovern DP; Hysi P; Ahmad T; van Heel DA; Moffatt MF; Carey A; Cookson WO; Jewell DP
    Hum Mol Genet; 2005 May; 14(10):1245-50. PubMed ID: 15790594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex insertion/deletion polymorphism in NOD1 (CARD4) is not associated with inflammatory bowel disease susceptibility in East Anglia panel.
    Tremelling M; Hancock L; Bredin F; Sharpstone D; Bingham SA; Parkes M
    Inflamm Bowel Dis; 2006 Oct; 12(10):967-71. PubMed ID: 17012967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease.
    Molnar T; Hofner P; Nagy F; Lakatos PL; Fischer S; Lakatos L; Kovacs A; Altorjay I; Papp M; Palatka K; Demeter P; Tulassay Z; Nyari T; Miheller P; Papp J; Mandi Y; Lonovics J;
    Dig Liver Dis; 2007 Dec; 39(12):1064-70. PubMed ID: 17964870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of NOD1/CARD4 and NOD2/CARD15 genetic variations in lung cancer risk.
    Ozbayer C; Kurt H; Bayramoglu A; Gunes HV; Metintas M; Degirmenci İ; Oner KS
    Inflamm Res; 2015 Oct; 64(10):775-9. PubMed ID: 26238283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease.
    Heliö T; Halme L; Lappalainen M; Fodstad H; Paavola-Sakki P; Turunen U; Färkkilä M; Krusius T; Kontula K
    Gut; 2003 Apr; 52(4):558-62. PubMed ID: 12631669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for association of OCTN genes and IBD5 with ulcerative colitis.
    Waller S; Tremelling M; Bredin F; Godfrey L; Howson J; Parkes M
    Gut; 2006 Jun; 55(6):809-14. PubMed ID: 16361305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of single-nucleotide polymorphisms in the intron 9 region of the nucleotide oligomerization domain-1 gene in ulcerative colitis patients of North India.
    Verma R; Ahuja V; Paul J
    J Gastroenterol Hepatol; 2012 Jan; 27(1):96-103. PubMed ID: 21722177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic association and phenotypic correlation of TLR4 but not NOD2 variants with Tunisian inflammatory bowel disease.
    Feki S; Bouzid D; Abida O; Chtourou L; Elloumi N; Toumi A; Hachicha H; Amouri A; Tahri N; Masmoudi H
    J Dig Dis; 2017 Nov; 18(11):625-633. PubMed ID: 29055077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of IL23R, TNFRSF1A, and HLA-DRB1*0103 allele variants with inflammatory bowel disease phenotypes in the Finnish population.
    Lappalainen M; Halme L; Turunen U; Saavalainen P; Einarsdottir E; Färkkilä M; Kontula K; Paavola-Sakki P
    Inflamm Bowel Dis; 2008 Aug; 14(8):1118-24. PubMed ID: 18338763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of NOD1 (CARD4) insertion/deletion polymorphism with susceptibility to IBD: a meta-analysis.
    Lu WG; Zou YF; Feng XL; Yuan FL; Gu YL; Li X; Li CW; Jin C; Li JP
    World J Gastroenterol; 2010 Sep; 16(34):4348-56. PubMed ID: 20818820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease.
    Henckaerts L; Pierik M; Joossens M; Ferrante M; Rutgeerts P; Vermeire S
    Gut; 2007 Nov; 56(11):1536-42. PubMed ID: 17595233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between IBD5 and Crohn's disease in Japanese patients demonstrates population-specific differences in inflammatory bowel disease.
    Tosa M; Negoro K; Kinouchi Y; Abe H; Nomura E; Takagi S; Aihara H; Oomori S; Sugimura M; Takahashi K; Hiwatashi N; Takahashi S; Shimosegawa T
    Scand J Gastroenterol; 2006 Jan; 41(1):48-53. PubMed ID: 16373276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation in NOD1/CARD4 and NOD2/CARD15 immune sensors and risk of osteoporosis.
    Soyocak A; Özgen M; Turgut Coşan D; Kurt H; Doğaner F; Armağan O; Değirmenci İ; Şahin Mutlu F
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32578848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population.
    Gazouli M; Mantzaris G; Kotsinas A; Zacharatos P; Papalambros E; Archimandritis A; Ikonomopoulos J; Gorgoulis VG
    World J Gastroenterol; 2005 Feb; 11(5):681-5. PubMed ID: 15655821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
    Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
    Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DLG5 variants do not influence susceptibility to inflammatory bowel disease in the Scottish population.
    Noble CL; Nimmo ER; Drummond H; Smith L; Arnott ID; Satsangi J
    Gut; 2005 Oct; 54(10):1416-20. PubMed ID: 15843420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.